Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 8
Barrier function and microbiotic dysbiosis in atopic dermatitis
Authors Seite S, Bieber T
Received 1 July 2015
Accepted for publication 6 August 2015
Published 15 September 2015 Volume 2015:8 Pages 479—483
DOI https://doi.org/10.2147/CCID.S91521
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 5
Editor who approved publication: Dr Jeffrey Weinberg
Sophie Seite,1 Thomas Bieber2
1La Roche-Posay Dermatological Laboratories, Asnières, France; 2Department of Dermatology and Allergy, Friedrich-Wilhelms-University, Bonn, Germany
Abstract: Atopic dermatitis (AD) or atopic eczema is the common inflammatory skin disorder, the prevalence of which has considerably increased during the last 30 years. It affects 15%–30% of children and 2%–10% of adults. AD characteristically alternates between periods of exacerbation or flares and periods of remission, which may be therapeutically induced or spontaneous. Current knowledge about AD includes abnormalities of the skin barrier (physical and chemical), the immune barrier, and more recently, the microbial barrier or microbiota. There is growing evidence for a tight relationship between them. To obtain satisfactory control of this condition, the clinical strategy to manage AD involves prescribing both anti-inflammatory medications and dermocosmetic products. The role of the physician is therefore to advise the patient with regard to hygiene measures aimed to help to improve these three barriers or to prevent any further deterioration.
Keywords: atopic dermatitis, eczema, skin barrier, microbiome, immunity, dermocosmetic
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.